SEC Form D · Amendment · filed April 1, 2020
Ralexar Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Jason J. Hong · New York, NYDirectorStephen Tullman · Wayne, PAExec · DirectorSomasundaram Subramaniam · New York, NYDirectorNeal Walker · Wayne, PADirectorDavid Pfeiffer · Wayne, PAExec · DirectorTodd B. Allen · Roswell, GADirectorPatrick Porter · New Bern, NCExec · DirectorMark Heaney · Dubai, C0DirectorGeorge P. Rauch · Dallas, TXExec · DirectorDaniel Freed · Chicago, ILDirectorCristobal K. Conde · London, United KingdomDirectorMatthew B. Bass · New York, NYExec · DirectorJohn G. Jordan · Austin, TXDirectorSabrina Foster · Grand Cayman, Cayman IslandsDirectorThomas J. Powell · Reno, NVExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗